Morgan Stanley’s Abeona Therapeutics ABEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.51M | Buy |
|
|||||
|
2025
Q1 | $1.5M | Buy |
|
|||||
|
2024
Q4 | $729K | Sell |
|
|||||
|
2024
Q3 | $1.12M | Sell |
|
|||||
|
2024
Q2 | $2.53M | Buy |
|
|||||
|
2024
Q1 | $225K | Sell |
|
|||||
|
2023
Q4 | $159K | Buy |
|
|||||
|
2023
Q3 | $19.8K | Hold |
|
|||||
|
2023
Q2 | $19K | Hold |
|
|||||
|
2023
Q1 | $13.3K | Sell |
|
|||||
|
2022
Q4 | $14.5K | Sell |
|
|||||
|
2022
Q3 | $14K | Sell |
|
|||||
|
2022
Q2 | $35K | Sell |
|
|||||
|
2022
Q1 | $55K | Sell |
|
|||||
|
2021
Q4 | $1.14M | Buy |
|
|||||
|
2021
Q3 | $1.49M | Sell |
|
|||||
|
2021
Q2 | $2.83M | Buy |
|
|||||
|
2021
Q1 | $996K | Buy |
|
|||||
|
2020
Q4 | $283K | Buy |
|
|||||
|
2020
Q3 | $99K | Sell |
|
|||||
|
2020
Q2 | $425K | Buy |
|
|||||
|
2020
Q1 | $303K | Sell |
|
|||||
|
2019
Q4 | $486K | Buy |
|
|||||
|
2019
Q3 | $231K | Buy |
|
|||||
|
2019
Q2 | $294K | Buy |
|
|||||
|
2019
Q1 | $438K | Sell |
|
|||||
|
2018
Q4 | $504K | Sell |
|
|||||
|
2018
Q3 | $1.36M | Sell |
|
|||||
|
2018
Q2 | $3.6M | Sell |
|
|||||
|
2018
Q1 | $4.92M | Sell |
|
|||||
|
2017
Q4 | $6.29M | Buy |
|
|||||
|
2017
Q3 | $708K | Buy |
|
|||||
|
2017
Q2 | $232K | Sell |
|
|||||
|
2017
Q1 | $523K | Buy |
|
|||||
|
2016
Q4 | $19K | Sell |
|
|||||
|
2016
Q3 | $43K | Buy |
|
|||||
|
2016
Q2 | $15K | Sell |
|
|||||
|
2016
Q1 | $29K | Sell |
|
|||||
|
2015
Q4 | $39K | Sell |
|
|||||
|
2015
Q3 | $149K | Sell |
|
|||||
|
2015
Q2 | $611K | Buy |
|
|||||
|
2015
Q1 | $3K | Buy |
|